| scholarly article | Q13442814 |
| P2093 | author name string | I Ginzburg | |
| A Heicklen-Klein | |||
| P2860 | cites work | O-glycosylation of eukaryotic transcription factors: implications for mechanisms of transcriptional regulation | Q24296741 |
| REST: A mammalian silencer protein that restricts sodium channel gene expression to neurons | Q24312038 | ||
| The neuron-restrictive silencer factor (NRSF): a coordinate repressor of multiple neuron-specific genes | Q24314740 | ||
| The zinc finger protein CTCF binds to the APBbeta domain of the amyloid beta-protein precursor promoter. Evidence for a role in transcriptional activation | Q24315790 | ||
| Cloning of Nrf1, an NF-E2-related transcription factor, by genetic selection in yeast | Q24321410 | ||
| Establishment of a noradrenergic clonal line of rat adrenal pheochromocytoma cells which respond to nerve growth factor | Q24561804 | ||
| The early response gene NGFI-C encodes a zinc finger transcriptional activator and is a member of the GCGGGGGCG (GSG) element-binding protein family | Q24597917 | ||
| Cloning and sequencing of the cDNA encoding a core protein of the paired helical filament of Alzheimer disease: identification as the microtubule-associated protein tau | Q24648590 | ||
| Involvement of mature tau isoforms in the stabilization of neurites in PC12 cells | Q67865402 | ||
| Association of tau protein with microtubules in living cells | Q69884140 | ||
| The initiator element and proximal upstream sequences affect transcriptional activity and start site selection in the amyloid beta-protein precursor promoter | Q71246709 | ||
| Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei | Q27860728 | ||
| A Family of Ammonium Transporters in Saccharomyces cerevisiae† | Q27930253 | ||
| Analysis of the DNA-binding and activation properties of the human transcription factor AP-2 | Q28271397 | ||
| The serotonin 1a receptor gene contains a TATA-less promoter that responds to MAZ and Sp1 | Q28278426 | ||
| The "initiator" as a transcription control element | Q29619589 | ||
| Differential regulation of amyloid-beta-protein mRNA expression within hippocampal neuronal subpopulations in Alzheimer disease | Q33554847 | ||
| Neu differentiation factor stimulates phosphorylation and activation of the Sp1 transcription factor | Q33957454 | ||
| Identification of cDNA clones for the human microtubule-associated protein tau and chromosomal localization of the genes for tau and microtubule-associated protein 2. | Q34166092 | ||
| Molecular cloning and characterization of a human DNA binding factor that represses transcription | Q34456777 | ||
| The expression of the amyloid precursor protein (APP) is regulated by two GC-elements in the promoter | Q35010710 | ||
| Regulation of the differentiation of PC12 pheochromocytoma cells | Q35032923 | ||
| Synthetic promoter elements obtained by nucleotide sequence variation and selection for activity | Q35103817 | ||
| A single zinc finger motif in the silencing factor REST represses the neural-specific type II sodium channel promoter. | Q35990792 | ||
| Expression of a family of POU-domain protein regulatory genes during development of the central nervous system | Q36064926 | ||
| Identification of a functional silencer element involved in neuron-specific expression of the synapsin I gene | Q36108580 | ||
| Nerve growth factor-induced neurite outgrowth in PC12 cells involves the coordinate induction of microtubule assembly and assembly-promoting factors | Q36213686 | ||
| Regulation of microtubule protein levels during cellular morphogenesis in nerve growth factor-treated PC12 cells | Q36218604 | ||
| Sea urchin early histone H2A modulator binding factor 1 is a positive transcription factor also for the early histone H3 gene | Q36435688 | ||
| A nerve growth factor-induced gene encodes a possible transcriptional regulatory factor. | Q36472744 | ||
| Structure and expression of the mouse necdin gene. Identification of a postmitotic neuron-restrictive core promoter | Q36790661 | ||
| Evidence for RNA synthesis-dependent and -independent pathways in stimulation of neurite outgrowth by nerve growth factor | Q37596585 | ||
| Multiple protein complexes, including AP2 and Sp1, interact with a specific site within the rat preprotachykinin-A promoter | Q38293324 | ||
| Transcriptional analysis of acetylcholine receptor alpha 3 gene promoter motifs that bind Sp1 and AP2. | Q38296619 | ||
| An region upstream of the gene promoter for the β-amyloid precursor protein interacts with proteins from nuclear extracts of the human brain and PC12 cells | Q38334997 | ||
| Role of the zinc(II) ions in the structure of the three-finger DNA binding domain of the Sp1 transcription factor | Q38339165 | ||
| Regulation of the neural-specific gene VGF in PC12 cells. Identification of transcription factors interacting with NGF-responsive elements | Q38345251 | ||
| Dimer formation by ternary complex factor ELK-1. | Q40906065 | ||
| Activator protein-2 mediates transcriptional activation of the CYP11A1 gene by interaction with Sp1 rather than binding to DNA. | Q40935582 | ||
| Thionein (apometallothionein) can modulate DNA binding and transcription activation by zinc finger containing factor Sp1. | Q41179510 | ||
| A novel nerve growth factor-responsive element in the stromelysin-1 (transin) gene that is necessary and sufficient for gene expression in PC12 cells | Q41349370 | ||
| Changes in the colchicine susceptibility of microtubules associated with neurite outgrowth: studies with nerve growth factor-responsive PC12 pheochromocytoma cells | Q41445165 | ||
| Zinc Metabolism in the Brain: Relevance to Human Neurodegenerative Disorders | Q41636058 | ||
| GC box binding induces phosphorylation of Sp1 by a DNA-dependent protein kinase | Q41718635 | ||
| Transgenic mice expressing beta-galactosidase in mature neurons under neuron-specific enolase promoter control | Q46168479 | ||
| Identification of a tau promoter region mediating tissue-specific-regulated expression in PC12 cells | Q48065590 | ||
| Structure and novel exons of the human tau gene | Q48149325 | ||
| Positive and negative regulatory elements for the expression of the Alzheimer's disease amyloid precursor-encoding gene in mouse | Q48181345 | ||
| Brain levels of microtubule-associated protein tau are elevated in Alzheimer's disease: a radioimmuno-slot-blot assay for nanograms of the protein | Q48446922 | ||
| Silencing the type II sodium channel gene: a model for neural-specific gene regulation | Q48466004 | ||
| A (G+C)-rich motif in the aldolase C promoter functions as a constitutive transcriptional enhancer element | Q49044999 | ||
| Distribution of isoforms of the microtubule-associated protein tau in grey and white matter areas of human brain: a two-dimensional gelelectrophoretic analysis | Q49120737 | ||
| Positive and negative elements contribute to the cell-specific expression of the rat dopamine beta-hydroxylase gene | Q49123750 | ||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 1408-18 | |
| P577 | publication date | 2000-10-01 | |
| P1433 | published in | Journal of Neurochemistry | Q6295643 |
| P1476 | title | Tau promoter confers neuronal specificity and binds Sp1 and AP-2 | |
| P478 | volume | 75 |
| Q88256130 | Altered microRNA, mRNA, and Protein Expression of Neurodegeneration-Related Biomarkers and Their Transcriptional and Epigenetic Modifiers in a Human Tau Transgenic Mouse Model in Response to Developmental Lead Exposure |
| Q37186173 | Alzheimer’s Amyloid-β Oligomers Rescue Cellular Prion Protein Induced Tau Reduction via the Fyn Pathway |
| Q41583234 | Association between Polymorphisms of the AKT1 Gene Promoter and Risk of the Alzheimer's Disease in a Chinese Han Population with Type 2 Diabetes |
| Q27021084 | Circulating microRNAs in Alzheimer's disease: the search for novel biomarkers |
| Q34344867 | Concerted perturbation observed in a hub network in Alzheimer's disease |
| Q46309586 | Copper and Alzheimer's Disease |
| Q91712883 | Current understanding of metal ions in the pathogenesis of Alzheimer's disease |
| Q48521070 | DNA methylation of Alzheimer disease and tauopathy-related genes in postmortem brain |
| Q34655631 | Enhanced taupathy and AD-like pathology in aged primate brains decades after infantile exposure to lead (Pb). |
| Q38294385 | GC Box-binding Transcription Factors Control the Neuronal Specific Transcription of the Cyclin-dependent Kinase 5 Regulator p35 |
| Q34202948 | Integrated multi-cohort transcriptional meta-analysis of neurodegenerative diseases. |
| Q36603312 | Lifespan profiles of Alzheimer's disease-associated genes and products in monkeys and mice |
| Q36847737 | Links between copper and cholesterol in Alzheimer's disease |
| Q50520724 | Mithramycin A Alleviates Cognitive Deficits and Reduces Neuropathology in a Transgenic Mouse Model of Alzheimer's Disease |
| Q39636390 | Mithramycin A suppresses expression of the human melanoma-associated gene ABCB8. |
| Q41328860 | Molecular systems evaluation of oligomerogenic APP(E693Q) and fibrillogenic APP(KM670/671NL)/PSEN1(Δexon9) mouse models identifies shared features with human Alzheimer's brain molecular pathology. |
| Q49126350 | Neuronal precursor-specific activity of a human doublecortin regulatory sequence |
| Q35844758 | Regulation of human MAPT gene expression |
| Q39920234 | Regulation of prion gene expression by transcription factors SP1 and metal transcription factor-1. |
| Q39274764 | Secondary RNA structure and nucleotide specificity contribute to internal initiation mediated by the human tau 5' leader |
| Q30541295 | Short-term treatment with tolfenamic acid improves cognitive functions in Alzheimer's disease mice |
| Q37417119 | Sp1 and Sp3 regulate transcription of the cyclin-dependent kinase 5 regulatory subunit 2 (p39) promoter in neuronal cells |
| Q36789895 | Tau exon 10 alternative splicing and tauopathies |
| Q34730572 | Tau function and dysfunction in neurons: its role in neurodegenerative disorders |
| Q48428753 | Tau negative frontal lobe dementia at 17q21: significant finemapping of the candidate region to a 4.8 cM interval |
| Q50306250 | The LEARn model: an epigenetic explanation for idiopathic neurobiological diseases |
| Q39030830 | Tolfenamic acid downregulates BACE1 and protects against lead-induced upregulation of Alzheimer's disease related biomarkers |
| Q35264520 | Tolfenamic acid reduces tau and CDK5 levels: implications for dementia and tauopathies. |
| Q43106647 | Transcription factor Sp1 inhibition, memory, and cytokines in a mouse model of Alzheimer's disease |
| Q37535111 | miRNAs: Key Players in Neurodegenerative Disorders and Epilepsy |
Search more.